The IL-33/ST2 axis promotes the development of primary Sjogren’s syndrome by activating salivary epithelial cells and the type 1 immune response in a mouse model of experimental Sjogren’s syndrome [185]. The gene discussed is IL33; the disease is Sjogren syndrome.